For Ang-II-stimulating AHM, mortality risk (HR = 0.86 95% CI = 0.82–0.91) and dementia/mortality risk (HR = 0.87; 95% CI = 0.84–0.91) was lower compared to Ang-II-inhibiting AHM (Table 2). This evidence concerns the gene AGT and dementia.